KCT0004984尚未招募未知
Cardiovascular Disease (CVD) Risk Assessment and Lipid Lowering Treatment in Type 2 Diabetes Mellitus Patients Treated at Secondary and/or Tertiary Hospitals in Korea
Pfizer Upjohn Korea0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit(—)
- 性别
- All
入选标准
- •1. Adult Type 2 diabetes mellitus patients (=20 years) treated at secondary and/or tertiary hospitals
- •2. Patients with a record on cholesterol level at the time of enrollment
排除标准
- •1. Patients currently participating in other drug-controlled interventional study
- •2. Patients in severe or unstable medical conditions by physicians’ discretion during the recruitment
研究者
相似试验
招募中
4 期
A clinical trial for Heart Disease Risk assessment and treatment of patients with high risk.CTRI/2019/04/018723Dr Saurabha Nayak
招募中
不适用
Study of effect of yoga in reducing cardiovascular disease risks in communityCTRI/2017/09/009770Jawaharlal Institute of Post graduate Medical Education and Research JIPMER1,000
尚未招募
Unknown
A Heart Health check for Maori and Pacific People in HospitalCardiovascular - Coronary heart diseaseStroke - IschaemicPublic Health - Health service researchCardiovascular diseaseACTRN12624000920594Christchurch Hospital Pharmacy Department200
尚未招募
不适用
Evaluation of heart disease risk in type 2 Diabetes Mellitus patients using FRS, Q-RISK3, INTERHEART Risk Scores & their correlation with lipoprotein (a) level.CTRI/2022/08/044536Dr Ramesh Kumar Chandak
尚未招募
不适用
Assessment of cardio vascular risk by measurement of carotid intima-media thickness (cIMT) in adult type I Gaucher disease patients.Gaucher disease type Iglucocerebrosidase deficiency10027424NL-OMON29706Academisch Medisch Centrum140
